From Potential ‘Bloodbath’ To Promo Warnings: Semaglutide’s India Reckoning

 
• By Anju Ghangurde
  
obesity
Indian regulator cautions pharma on GLP-1 RA ads ahead of semaglutide LOE (Shutterstock)

More from Generics

More from Products